1Sreenan C, Lemke RP, Hudson Mason A, et al. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure[J]. Pediatrics, 2001, 107(5):1081-1083.
2Ahn HW, Shin WG, Park KJ, et al. Pharmaookinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea[J]. Res Commun Mol Pathol Pharmacol, 1999,105(1-2):105-113.
3Storm H, Stoltenberg L, Saugstad OD, et al. Beta-endorphin immunoreactivity levels in CSF after laryngeal chemoreflex activation correlate with apnoea duration in piglets[J].J Perinat Med, 1996,24(4): 363-372.
4Lowry JA, Jarrett RV, Wasserman G, et al. Theophylline toxicokinetics in premature newboms[J]. Arch Pediatr Adolesc Med, 2001,155 (8): 934-939.
5Lee TC, Charles B, Steer P, et al. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity [J]. Clin Pharmacol Ther,1997,61(6): 628-640.
6Bauer J,Maier K, Linderkamp O, et al. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea[J]. Pediatrics,2001,107(4): 660-663.
7Fang S, Sherwood RA, Gamsu HR, et al. Comparison of the effects of theophylline and caffeine on serum erythropoietin concentration in premature infants[J]. Eur J Pediatr, 1998,157(5):406-409.
8Yamazaki T, Kajiwara M,Itahashi K, et al. Low-dose doxapram therapy for idiopathic apnea of prematurity[J]. Pediatr Iht,2001,43(2):124-127.
9Poets CF,Darraj S, Bohnhorst B. Effect of doxapram on episodes of apnea,bradycardia and hypoxaemia in preterm infants [J]. Biol Neonate, 1999, 76(4):207-213.
10Huon C, Rey E, Mussat P. Low-dose doxaprarm for treatment of apnea following early weaning in very low birthweight infants: a randomized,double-blind study[J]. Acta Paediatr, 1998,87(11):1180-1184.
